The federal government will not make new deliveries of the Johnson & Johnson coronavirus next week, according to reports.
Vaccine delivery The two-dose Pfizer-BioNTech and Moderna will not be interrupted, The Washington Post reports citing an update by the CDC on expected vaccine delivery.
But there was no volume of new J&J headed the state in Thursday’s update. Biden’s management delivered 600,000 doses of the one-shot vaccine this week, less than nearly 8 million and 10 million weekly doses for the Pfizer and Moderna vaccines, respectively.
However, some states still rely on the J&J vaccine for hard-to-reach communities because they only need one time and are easier to collect than alternatives.
But they may have enough warehouses that local distributions will not be affected for weeks, medical officials said in the report.
“Everyone is hoping that this is just a small moment where we are going through and things will return to where it was before,” said Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials. newspaper
J&J has been doing mass production in the Netherlands after US production crashed 15 million doses in its Baltimore factory.
Emergent BioSolutions, the maker of J&J and AstraZeneca, mixes two different products. The Food and Drug Administration then told factories that long-standing problems had to be addressed before opening, including peeling paint and unsanitary conditions.